文献速递医学教育与科研方法

当我们谈论「均衡」时我们在谈论什么?评估均衡在临床研究伦理中应用的利益相关者访谈

What do we talk about when we talk about "equipoise"? Stakeholder interviews assessing the use of equipoise in clinical research ethics.
PubMed 文献 · Trials · 2023-03-18

该研究通过半结构化电话访谈,调查了15名临床研究者、15名研究伦理委员会主席和15名科学哲学家/生物伦理学家对临床试验伦理中「均衡」概念的定义与推理方式。43名受访者以7种逻辑上不同的方式定义均衡,最常见的定义(14人,31%)为「医师群体层面的分歧」;35/45(78%)认为该概念有帮助,但许多人承认缺乏清晰定义或操作化是个问题。结论指出定义存在显著差异,可能影响公平性与透明度并带来潜在伦理问题。

要点

  • 43名受访者以7种逻辑上不同的方式定义均衡,2人无法明确界定。
  • 最常见定义(14/43,31%)将均衡定义为医师群体层面的分歧。
  • 35/45(78%)认为均衡概念有帮助,但许多人指出缺乏清晰定义或操作化的问题。

核心结论

  • 受访者对均衡的定义存在显著差异,提示组内和组间在引用「均衡」时可能指向不同概念。
  • 这种非一致性可能影响公平性与透明度,并带来临床试验评估中的潜在伦理问题。

研究设计与样本

  • 半结构化访谈研究,就临床试验伦理对15名临床研究者、15名研究伦理委员会主席和15名科学哲学家/生物伦理学家进行电话访谈并转录。
  • 每位参与者回答一套标准化10个问题,其中4个专门关于均衡;采用改良扎根理论方法对回答进行分组和分析。

主要发现

  • 43名受访者以7种逻辑上不同的方式定义均衡,2名受访者无法明确界定。
  • 最常见的定义由14名受访者(31%)提出,将「均衡」定义为医师群体层面的分歧。
  • 受访者提供的定义在组间和组内均存在显著变异性。
  • 关于如何「操作化」均衡(即检查或检验其存在),受访者提供了7种替代方式,最常见的是与文献综述相关(15/45,33%)。
  • 绝大多数受访者(35/45,78%)认为该概念有帮助,但许多人承认缺乏清晰定义或操作化是个问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Equipoise, generally defined as uncertainty about the relative effects of the treatments being compared in a trial, is frequently referenced as an ethical standard for the conduct of randomized clinical trials. However, it seems to be defined in several different ways and may be used differently by different individuals. We explored how clinical researchers, chairs of research ethics boards, and philosophers of science define and reason with this term. METHODS: We completed semi-structured interviews about clinical trial ethics with 15 clinical researchers, 15 research ethics board chairs, and 15 philosophers of science/bioethicists. Each participant was asked a standardized set of 10 questions, 4 of which were specifically about equipoise. All interviews were conducted telephonically and transcribed. Responses were grouped and analysed via a modified grounded theory method. RESULTS: Forty-three respondents defined equipoise in 7 logically distinct ways, and 2 respondents could not explicitly define it. The most common definition, offered by 14 respondents (31%), defined "equipoise" as a disagreement at the level of a community of physicians. There was significant variability in definitions offered between and within groups. When asked how they would "operationalize" equipoise - i.e. check or test for its presence - respondents provided 7 alternatives, the most common being in relation to a literature review (15/45, 33%). The vast majority of respondents (35/45, 78%) felt the concept was helpful, though many acknowledged that the lack of a clear definition or operationalization was problematic. CONCLUSION: There is significant variation in definitions of equipoise offered by respondents, suggesting that parties within groups and between groups may be referring to different concepts when they reference "equipoise". This non-uniformity may impact fairness and transparency and opens the door to potential ethical problems in the evaluation of clinical trials - for instance, a patient may understand equipoise very differently than the researchers enrolling her in a trial, which could cause her agreement to participate to be based upon false premises.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Dewar B, Chevrier S, De Meulemeester J, et al. What do we talk about when we talk about "equipoise"? Stakeholder interviews assessing the use of equipoise in clinical research ethics. Trials. 2023. PMID: 36934250. doi:10.1186/s13063-023-07221-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。